Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2012 | 1 |
2013 | 2 |
2014 | 2 |
2015 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Toward improved effectiveness of bladder cancer immunotherapy.
Immunotherapy. 2015;7(10):1039-42. doi: 10.2217/imt.15.71. Epub 2015 Oct 28.
Immunotherapy. 2015.
PMID: 26507359
Free article.
No abstract available.
Oncolytic viruses as therapeutic cancer vaccines.
Bartlett DL, Liu Z, Sathaiah M, Ravindranathan R, Guo Z, He Y, Guo ZS.
Bartlett DL, et al.
Mol Cancer. 2013 Sep 11;12(1):103. doi: 10.1186/1476-4598-12-103.
Mol Cancer. 2013.
PMID: 24020520
Free PMC article.
Review.
Item in Clipboard
Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer.
Li J, O'Malley M, Urban J, Sampath P, Guo ZS, Kalinski P, Thorne SH, Bartlett DL.
Li J, et al.
Mol Ther. 2011 Apr;19(4):650-7. doi: 10.1038/mt.2010.312. Epub 2011 Jan 25.
Mol Ther. 2011.
PMID: 21266959
Free PMC article.
Item in Clipboard
First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.
Zeh HJ, Downs-Canner S, McCart JA, Guo ZS, Rao UN, Ramalingam L, Thorne SH, Jones HL, Kalinski P, Wieckowski E, O'Malley ME, Daneshmand M, Hu K, Bell JC, Hwang TH, Moon A, Breitbach CJ, Kirn DH, Bartlett DL.
Zeh HJ, et al.
Mol Ther. 2015 Jan;23(1):202-14. doi: 10.1038/mt.2014.194. Epub 2014 Oct 8.
Mol Ther. 2015.
PMID: 25292189
Free PMC article.
Clinical Trial.
Item in Clipboard
Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.
Okada H, Butterfield LH, Hamilton RL, Hoji A, Sakaki M, Ahn BJ, Kohanbash G, Drappatz J, Engh J, Amankulor N, Lively MO, Chan MD, Salazar AM, Shaw EG, Potter DM, Lieberman FS.
Okada H, et al.
Clin Cancer Res. 2015 Jan 15;21(2):286-94. doi: 10.1158/1078-0432.CCR-14-1790. Epub 2014 Nov 25.
Clin Cancer Res. 2015.
PMID: 25424847
Free PMC article.
Clinical Trial.
Item in Clipboard
NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells.
Muthuswamy R, Berk E, Junecko BF, Zeh HJ, Zureikat AH, Normolle D, Luong TM, Reinhart TA, Bartlett DL, Kalinski P.
Muthuswamy R, et al.
Cancer Res. 2012 Aug 1;72(15):3735-43. doi: 10.1158/0008-5472.CAN-11-4136. Epub 2012 May 16.
Cancer Res. 2012.
PMID: 22593190
Free PMC article.
Item in Clipboard
Integration of epidemiology, immunobiology, and translational research for brain tumors.
Okada H, Scheurer ME, Sarkar SN, Bondy ML.
Okada H, et al.
Ann N Y Acad Sci. 2013 May;1284(1):17-23. doi: 10.1111/nyas.12115.
Ann N Y Acad Sci. 2013.
PMID: 23651189
Free PMC article.
Item in Clipboard
Cite
Cite